journal article·2025-08Open access

Peptide‐Based Biomaterials as a Promising Tool for Cancer Radiotherapy

Qian Wang, Xinhui Chu, Jianfeng Liu

Advanced Science· Volume 12· Issue 31

Abstract

Abstract Radiotherapy (RT) is a mainstay therapeutic strategy for cancer; however, increasing radiation damage to tumor tissues while reducing the side effects on healthy tissues remains a great challenge. To address this issue, the use of biomaterials has proven promising. Recently, attention has been paid to peptide‐based biomaterials as platforms for enhancing radiotherapeutic efficacy. This review explores peptide‐based biomaterial‐mediated tumor RT, including radiosensitizers and radiopharmaceuticals, with the aim of introducing emerging radiosensitive methods and RT strategies using radiopharmaceuticals. The advantages of peptide‐based biomaterials, including controllable synthesis, good biocompatibility, targeting functions, and self‐assembly performance, are introduced. These parameters must be considered in the rational design and optimization of peptide‐based RT strategies. Peptide‐based radiosensitizers are generally divided into three categories: peptides as direct radiosensitizers, peptides as carriers of radiosensitizers, and targeted‐peptide‐modified radiosensitizers. Peptide‐based radiopharmaceuticals are known as peptide‐radionuclide conjugates (PRCs) and are categorized according to their peptide targets. Details of PRCs used in clinical studies and US Food and Drug Administration‐approved PRCs are also presented. Finally, challenges in the clinical translation of peptide‐based biomaterials as RT tools are highlighted.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Peptidase Inhibition and Analysis · Radiopharmaceutical Chemistry and Applications · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Advanced Medical Materials and Devices Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine Key Laboratory of Radiopharmacokinetics for Innovative Drugs Tianjin Institutes of Health Science Institute of Radiation Medicine Chinese Academy of Medical Sciences & Peking Union Medical College Tianjin 300192 P. R. China

Funding

National Key Research and Development Program of China · National Science Fund for Distinguished Young Scholars · National Natural Science Foundation of China · China Postdoctoral Science Foundation

References (100+)

Show source-provided references
1. 10.1002/adma.20180224410.1002/adma.201802244 ↗
2. 10.1038/s41575-019-0247-210.1038/s41575-019-0247-2 ↗
3. 10.1016/j.ajps.2024.10090310.1016/j.ajps.2024.100903 ↗
4. 10.1002/adma.20220637010.1002/adma.202206370 ↗
5. 10.1016/j.biomaterials.2024.12281410.1016/j.biomaterials.2024.122814 ↗
6. 10.1080/09553002.2022.204782510.1080/09553002.2022.2047825 ↗
7. 10.3389/fonc.2021.76869210.3389/fonc.2021.768692 ↗
8. 10.2147/IJN.S29043810.2147/IJN.S290438 ↗
9. 10.1002/slct.20240343110.1002/slct.202403431 ↗
10. 10.1038/s41571-022-00652-y10.1038/s41571-022-00652-y ↗
11. 10.1038/s41392-024-02041-610.1038/s41392-024-02041-6 ↗
12. 10.1007/s00259-025-07077-610.1007/s00259-025-07077-6 ↗
13. 10.1002/wnan.200610.1002/wnan.2006 ↗
14. 10.3389/fmed.2023.125079910.3389/fmed.2023.1250799 ↗
15. 10.1039/D3CS00805C10.1039/D3CS00805C ↗
16. 10.1016/j.pmatsci.2024.10137510.1016/j.pmatsci.2024.101375 ↗
17. 10.1016/j.mtcomm.2023.10644910.1016/j.mtcomm.2023.106449 ↗
18. 10.1016/j.addr.2020.06.02210.1016/j.addr.2020.06.022 ↗
19. 10.1038/s41467-024-47657-y10.1038/s41467-024-47657-y ↗
20. 10.1039/C9BM01212E10.1039/C9BM01212E ↗
21. 10.3390/polym1516335410.3390/polym15163354 ↗
22. 10.1016/j.bioactmat.2021.09.02910.1016/j.bioactmat.2021.09.029 ↗
23. 10.1146/annurev.ph.43.030181.00140510.1146/annurev.ph.43.030181.001405 ↗
24. 10.1038/s41392-023-01553-x10.1038/s41392-023-01553-x ↗
25. 10.1039/D0NR00143K10.1039/D0NR00143K ↗
26. 10.1016/j.jconrel.2019.11.02810.1016/j.jconrel.2019.11.028 ↗
27. 10.1016/j.tifs.2021.12.02710.1016/j.tifs.2021.12.027 ↗
28. 10.1021/ol800654n10.1021/ol800654n ↗
29. 10.1016/j.lmd.2024.10003110.1016/j.lmd.2024.100031 ↗
30. 10.1016/j.actbio.2021.10.03010.1016/j.actbio.2021.10.030 ↗
31. 10.3390/ph1510120110.3390/ph15101201 ↗
32. 10.1021/acs.accounts.7b0015910.1021/acs.accounts.7b00159 ↗
33. 10.3892/or.2017.577810.3892/or.2017.5778 ↗
34. 10.1016/j.peptides.2014.04.01910.1016/j.peptides.2014.04.019 ↗
35. 10.1080/02652048.2016.119490410.1080/02652048.2016.1194904 ↗
36. 10.1002/advs.20230432610.1002/advs.202304326 ↗
37. Antimicrobial Peptide Database http://aps.unmc.edu/AP/ (accessed: 4 2025).
38. 10.1039/D2TB00644H10.1039/D2TB00644H ↗
39. 10.1016/j.jafr.2022.10035310.1016/j.jafr.2022.100353 ↗
40. 10.1007/978-1-0716-0227-0_110.1007/978-1-0716-0227-0_1 ↗
41. 10.1517/13543776.2016.115881010.1517/13543776.2016.1158810 ↗
42. 10.1039/D3OB01229H10.1039/D3OB01229H ↗
43. 10.1111/1541-4337.1265510.1111/1541-4337.12655 ↗
44. 10.1016/j.biopha.2023.11499610.1016/j.biopha.2023.114996 ↗
45. 10.1016/j.tifs.2020.12.00210.1016/j.tifs.2020.12.002 ↗
46. 10.1002/biot.20230025610.1002/biot.202300256 ↗
47. 10.3389/fnut.2022.78015110.3389/fnut.2022.780151 ↗
48. 10.1080/10408398.2023.229182410.1080/10408398.2023.2291824 ↗
49. 10.1016/j.addr.2020.08.00810.1016/j.addr.2020.08.008 ↗
50. 10.1016/bs.mie.2021.07.00810.1016/bs.mie.2021.07.008 ↗
51. 10.1021/acs.oprd.2c0007410.1021/acs.oprd.2c00074 ↗
52. 10.1016/j.biotechadv.2022.10796810.1016/j.biotechadv.2022.107968 ↗
53. 10.3390/cells902049010.3390/cells9020490 ↗
54. 10.1016/j.bioactmat.2021.12.03310.1016/j.bioactmat.2021.12.033 ↗
55. 10.1021/acs.chemrev.7b0052210.1021/acs.chemrev.7b00522 ↗
56. 10.1016/j.cej.2023.14592310.1016/j.cej.2023.145923 ↗
57. 10.1021/acsnano.4c0506510.1021/acsnano.4c05065 ↗
58. 10.4049/jimmunol.179.8.503310.4049/jimmunol.179.8.5033 ↗
59. 10.1038/s41551-017-007810.1038/s41551-017-0078 ↗
60. 10.1016/j.jconrel.2014.06.02810.1016/j.jconrel.2014.06.028 ↗
61. 10.1016/j.jconrel.2021.10.02610.1016/j.jconrel.2021.10.026 ↗
62. 10.2174/138955752266622051612584210.2174/1389557522666220516125842 ↗
63. 10.1208/s12248-014-9687-310.1208/s12248-014-9687-3 ↗
64. 10.1021/acs.jmedchem.7b0031810.1021/acs.jmedchem.7b00318 ↗
65. 10.1124/dmd.123.00143710.1124/dmd.123.001437 ↗
66. 10.1002/EXP.2024003610.1002/EXP.20240036 ↗
67. 10.1021/acs.molpharmaceut.3c0036010.1021/acs.molpharmaceut.3c00360 ↗
68. 10.1016/j.envres.2023.11708610.1016/j.envres.2023.117086 ↗
69. 10.1007/s00259-024-06793-910.1007/s00259-024-06793-9 ↗
70. 10.1002/smll.20220220110.1002/smll.202202201 ↗
71. Huang M. · Pharm. · 2022 · 14 · 2511
72. 10.1186/s12943-023-01860-510.1186/s12943-023-01860-5 ↗
73. 10.1016/j.lfs.2020.11820610.1016/j.lfs.2020.118206 ↗
74. 10.1007/s00259-022-05842-510.1007/s00259-022-05842-5 ↗
75. 10.1186/s40364-020-00245-w10.1186/s40364-020-00245-w ↗
76. 10.2174/157489281266617020315193010.2174/1574892812666170203151930 ↗
77. 10.3390/biomedicines809030710.3390/biomedicines8090307 ↗
78. 10.1038/s41388-018-0213-410.1038/s41388-018-0213-4 ↗
79. 10.1093/rb/rbae01510.1093/rb/rbae015 ↗
80. 10.1038/s41392-021-00724-y10.1038/s41392-021-00724-y ↗
81. 10.3390/medicina5711120910.3390/medicina57111209 ↗
82. 10.1016/j.mam.2011.10.01510.1016/j.mam.2011.10.015 ↗
83. 10.1111/febs.1627410.1111/febs.16274 ↗
84. 10.1002/EXP.2022017310.1002/EXP.20220173 ↗
85. 10.1016/j.cell.2010.03.01510.1016/j.cell.2010.03.015 ↗
86. 10.1007/s10555-006-7886-910.1007/s10555-006-7886-9 ↗
87. 10.3109/14756366.2016.116162010.3109/14756366.2016.1161620 ↗
88. 10.1016/j.biomaterials.2016.04.03910.1016/j.biomaterials.2016.04.039 ↗
89. 10.1002/btm2.1070210.1002/btm2.10702 ↗
90. 10.1021/acsami.9b2129610.1021/acsami.9b21296 ↗
91. 10.1002/adfm.20230041610.1002/adfm.202300416 ↗
92. 10.1039/D4TB01860E10.1039/D4TB01860E ↗
93. 10.1039/D3TB01311A10.1039/D3TB01311A ↗
94. 10.1002/EXP.2023012710.1002/EXP.20230127 ↗
95. 10.1038/s41467-022-35033-710.1038/s41467-022-35033-7 ↗
96. 10.1039/D4SC04261A10.1039/D4SC04261A ↗
97. 10.1021/acs.biomac.3c0145310.1021/acs.biomac.3c01453 ↗
98. 10.1002/anie.20221282910.1002/anie.202212829 ↗
99. 10.1016/j.cej.2025.16130310.1016/j.cej.2025.161303 ↗
100. 10.1021/acsnano.9b0574910.1021/acsnano.9b05749 ↗